
|Articles|February 1, 2005
Adherence to glaucoma therapy of vital importance
New Orleans—Patient adherence to prostaglandin analogue or prostamide therapy for glaucoma is high but not perfect. There are still opportunities to improve adherence to therapy with these drugs, according to Jacob Wilensky, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Opus Genetics has Type B RMAT meeting with FDA for its gene therapy candidate, OPGx-LCA5
2
4DMT releases positive interim 1.5- to 3.5-year data from phase 1/2 PRISM trial
3
What ‘I’m Fine’ Really Means: An Open Letter from a Thyroid Eye Disease (TED) Patient
4
AAO 2025: A study of retinal vasculitis events with intravitreal agents
5


















































.png)


